Vicor Investing Cash Flow decreased by 123.5% to -$12.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 172.2%, from -$4.55M to -$12.39M. Over 2 years (FY 2023 to FY 2025), Investing Cash Flow shows an upward trend with a -22.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$12.01M | $2.32M | -$14.20M | -$14.40M | -$10.09M | -$8.54M | -$7.66M | -$7.16M | -$7.27M | -$6.14M | -$8.46M | -$1.74M | -$4.55M | -$6.20M | -$4.02M | -$5.54M | -$12.39M |
| QoQ Change | — | +119.3% | -712.6% | -1.5% | +29.9% | +15.4% | +10.3% | +6.5% | -1.5% | +15.5% | -37.7% | +79.5% | -162.1% | -36.4% | +35.2% | -37.9% | -123.5% |
| YoY Change | — | — | — | — | -535.4% | +39.9% | +46.8% | — | +27.9% | +28.1% | -10.3% | +75.8% | +37.4% | -1.0% | +52.4% | -219.3% | -172.2% |